74 search results for: patient burden

Expert Interview with Dr Jason Hawkes
Dermatology
Expert Interview with Dr Jason Hawkes
expert video

Join Dr. Hawkes as he discusses what burdens and challenges CSU patients might expect and help identify that there are immune functions responsible for their symptoms not an external cause.

View more
Loss of Smell is a Key Symptom of CRSwNP
Rhinology
Loss of Smell is a Key Symptom of CRSwNP
interactivity

Learn how loss of smell in CRSwNP is a key symptom for both patients and providers.

View more
Skin Dyspigmentation In Prurigo Nodularis (PN)
Dermatology
Skin Dyspigmentation In Prurigo Nodularis (PN)
interactivity

This infographic illustrates the clinical manifestations, pathophysiology and impact on patients of skin dyspigmentation in Prurigo Nodularis.

View more
ADVENT in Orlando, FL 2025
Congress
7
March
2025
Congress
ADVENT in Orlando, 2025

Type 2 inflammation contributes to many dermatologic diseases, which may lead to potentially life-changing burdens and challenges to patients and caregivers. By uncovering the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP, we can move forward in our understanding of each disease. Join global experts for an educational symposium on March 8th that will uncover the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP and explore questions driving current research in each disease.

Partnering With <b>Patient</b>s: Scores That Matter in CRSwNP
Rhinology
Partnering With Patients: Scores That Matter in CRSwNP
interactivity

Learn how partnering with patients and considering the clinical relevance of symptom improvements can improve patient quality of life

View more
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma <b>Patient</b>s
Pulmonology
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

View more
Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease <b>Burden</b>
Dermatology
Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease Burden
expert video

In this clip from the April WCPD 2025 symposium, Dr Paula Luna discusses how moderate-to-severe AD may hinder growth in pediatric patients.

View more
CRSwNP at Center Stage: Impact of Biologics in <b>Patient</b>s with Co-existing Type 2 Asthma
Pulmonology
CRSwNP at Center Stage: Impact of Biologics in Patients with Co-existing Type 2 Asthma
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Philippe Gevaert explains how biologic options for uncontrolled CRSwNP are increasing, and phase 3 studies of approved biologics show improved outcomes and decreased SCS use/surgery in patients with CRSwNP. Additionally, he explains how biologics targeting type 2 inflammatory pathophysiology potentially improve outcomes for eligible patients with co-existing CRSwNP and asthma.

View more
Type 2 Inflammatory Diseases Can Negatively Impact <b>Patient</b>s and Their Caregivers
Type 2 Inflammation
Type 2 Inflammatory Diseases Can Negatively Impact Patients and Their Caregivers
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof Oscar Palomares highlights the substantial impact of type 2 inflammatory diseases on the quality of life of patients and their caregivers.

View more
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
Type 2 Inflammation
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
videoanimation

Experts from different specialties use a case-based discussion to understand type 2 inflammatory diseases from a nurse practitioner perspective.

View more
The Potential Sequelae of Missed Opportunities: How Systemic Type 2 Inflammation Can Shape a <b>Patient</b>'s Life
Dermatology
The Potential Sequelae of Missed Opportunities: How Systemic Type 2 Inflammation Can Shape a Patient's Life
expert video

Dr. Nicole Chase describes a potential hypothesis for the link between the shift to an industrialized society and the rise in type 2 inflammatory diseases, highlighting the loss of immunomodulatory mechanisms driven by helminthic infections. She explains how unopposed immune responses to common environmental allergens may cause chronic type 2 inflammation, manifesting throughout the body.

View more
GUF PNG
On Demand
Translating the Science of CSU: From Pathogenesis to Patient Outcomes

Watch as Drs. Michihiro Hide, Marta Ferrrer, and Ana M. Giménez-Arnau discuss chronic spontaneous urticaria (CSU) and highlight the unmet needs, importance of disease control, and emerging therapies.